Charles River Labs Buys KF Cambodia to Bolster Supply Chain
Charles River Laboratories is acquiring K.F. (Cambodia) Ltd, a Cambodian supplier, for $510 million. This acquisition aims to strengthen control over the non-human primate supply chain, reduce operational costs, and effectively mitigate potential risks related to biosecurity and legal compliance. The transaction is expected to close in early 2026. The acquisition demonstrates Charles River's commitment to securing its supply chain and mitigating risks associated with sourcing non-human primates, which are crucial for preclinical research and drug development.
